Ignite Creation Date:
2024-05-06 @ 9:26 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02985463
Status:
UNKNOWN
Last Update Posted:
2020-08-27
First Post:
2016-12-03
Brief Title:
Left Atrial Appendage Occlusion and Biomarker Evaluation
Sponsor:
Universitätsmedizin Mannheim
Organization:
Universitätsmedizin Mannheim
Study Overview
Official Title:
Left Atrial Appendage Occlusion and Biomarker Evaluation
Status:
UNKNOWN
Status Verified Date:
2020-08
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LABEL
Brief Summary:
Left Atrial Appendage Occlusion and Biomarker Evaluation LABEL is a single-center prospective and observational study evaluating changes of the expression of biomarkers in eligible patients before and after percutaneous implantation of a left atrial appendage LAA occlusion device at mid-term follow-up
Detailed Description:
This study will evaluate the changes of different types of biomarkers before and after successful percutaneous implantation of an LAA occlusion device
Biomarker evaluation will focus on blood derived biomarkers including neurohormones proteins cytokines microRNAs and metabolomics
Biomarker evaluation will focus on blood derived biomarkers including neurohormones proteins cytokines microRNAs and metabolomics
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None